The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of combining genotype-guided irinotecan (Iri) with 5FU, leucovorin (LV), oxaliplatin (Ox), and docetaxel (Tax) (gFOLFOXIRITAX): The I-FLOAT phase 1 dose-escalation study for advanced upper GI cancers.
 
Koosha Paydary
No Relationships to Disclose
 
Aurelie Desgardin
No Relationships to Disclose
 
Chih-Yi Liao
Consulting or Advisory Role - Exelixis; Incyte; Ipsen; Lexicon
Speakers' Bureau - Eisai; Exelixis
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Eisai; Exelixis; Incyte; Ipsen
 
Ardaman Shergill
Consulting or Advisory Role - Catalyst Pharmaceuticals; Triptych Health Partners
Research Funding - Daiichi Sankyo/Lilly (Inst); Hutchison MediPharma (Inst); InhibRx (Inst); Merck (Inst); Seattle Genetics/Astellas (Inst); TP Therapeutics (Inst); verastem (Inst)
 
Natalie Marie Reizine
No Relationships to Disclose
 
Stephanie Moya
No Relationships to Disclose
 
Bryan Peterson
No Relationships to Disclose
 
Katherine Reyes
No Relationships to Disclose
 
Chanelle Robinzine
No Relationships to Disclose
 
Belen Martinez-Caro Aguado
No Relationships to Disclose
 
Christine Racette
No Relationships to Disclose
 
Elena Ignatiev
No Relationships to Disclose
 
Anu Radha Neerukonda
No Relationships to Disclose
 
Yuan Ji
Stock and Other Ownership Interests - Bayesoft; Bayesoft (I)
Consulting or Advisory Role - Astellas Pharma
Research Funding - Abbvie (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Sanofi
 
Blase N. Polite
Honoraria - American Journal of Managed Care; Genzyme; HMP; Physicans' Education Resource; Simon-Kucher and Partners
Consulting or Advisory Role - Cancer Expert Now
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Institute for Clinical and Economic Review; Tapestry Pharmaceuticals
 
Daniel V.T. Catenacci
Honoraria - Amgen; Archer; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Gritstone Bio; Guardant Health; Lilly; Merck; Natera; Novartis; Pieris Pharmaceuticals; QED Therapeutics; Seagen; Taiho Pharmaceutical; Tempus; Zymeworks
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Genentech/Roche; Guardant Health; Lilly; Merck; Seagen; Taiho Pharmaceutical; Zymeworks
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca; Genentech; Guardant Health; Lilly; Merck; Tempus